BRAUN MATHIAS,BUSACCA CARL ALAN,CHEN FENG-JING,GUMP EDWIN LOUIS,MAJESKA JENNESS B.,PENNINO SCOTT,QIU FENGHE,VILLAGRA MARIA FERNANDA
申请号：
NZ62635313
公开号：
NZ626353A
申请日:
2013.01.10
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
Described are various methods for stabilizing pharmaceutical formulations of a specific Hepatitis C Viral (HCV) inhibitor of formula (I) against the formation of a particular genotoxic degradation product. Such methods include temperature control, moisture control, excipient control, capsule shell control, basification and a reconstitution approach.
